Where does Craig Basson work?

Craig Basson is Chief Medical Officer, President of R&D at Variant Bio.

Where did Craig Basson go to school?

Craig Basson studied at Yale School of Medicine (MD, PhD, Medicine, Experimental Pathology); University of Oxford (MSc, Physiological Sciences); Washington University in St. Louis (BA, MA, Biology, French).

Craig Basson

Chief Medical Officer, President of R&D at Variant Bio

Greater Boston

Find your path to Craig

532 people in our graph share verified history with Craig — schools, employers, funds. One of them is your warm intro.

Anthony PhilippakisunlockedCraig: together at Brigham and Women's Hospital (2009–2015)

×4Craig: together at Harvard Medical School

×3Craig: together at Brigham and Women's Hospital

×2Craig: together at University of Oxford

Chief Medical Officer, President of R&D at Variant Bio

Intro paths

→

In turn, Craig can intro founders to Variant Bio's investors below.

Variant Bio's investors · 5

Alta PartnersJackson · $1M – $12M checks Dimension CapitalSan Francisco · $1M – $10M checks · since 2019 General CatalystSan Francisco · $30M checks Lux CapitalNew York · $100K – $100M checks SoftBank Vision FundLondon

Co-founders at Variant Bio

Kaja WasikExecutive Officer, Director

Andrew FarnumChief Executive Officer

Stephane CastelCo-Founder, Chief Scientific & Technology Officer

Experience

Variant BioChief Medical Officer; President, R&Dcurrent2026 — presentSeattle, Washington and Boston, Massachusetts
Brigham and Women's HospitalAttending Physiciancurrent2015 — presentBoston, Massachusetts, United States
Harvard Medical SchoolSenior Lecturercurrent2015 — presentBoston, Massachusetts, United States
Olatec Therapeutics LLCIndependent Board Director2022 — 2026
Bitterroot BioChief Medical Officer2022 — 2026Palo Alto, CA and Needham, MA
Berlin Cures Holding AGIndependent Board Director2024 — 2025
Boston PharmaceuticalsBoard and company advisor / consultant2022 — 2023
Boston PharmaceuticalsChief Medical Officer2020 — 2022Cambridge, Massachusetts
Boston PharmaceuticalsCo-Chief Executive Officer (ad interim)2021 — 2022Cambridge, Massachusetts, United States
Novartis Institutes for BioMedical ResearchVice President, Global Translational Medicine Head (Cardiovascular and Metabolism)2014 — 2020
Novartis Institutes for BioMedical ResearchVice President, Global Translational Medicine Head (Cardiovascular)2010 — 2014
Weill Cornell Medical CollegeGladys and Roland Harriman Professor of Medicine; Director, Cardiovascular Research1997 — 2010
Harvard Medical SchoolInstructor in Medicine1996 — 1997
Harvard Medical SchoolPostdoctoral Fellow in Genetics1992 — 1996
Brigham and Women's HospitalFellow in Cardiovascular Disease1992 — 1996
Johns Hopkins HospitalIntern/Resident in Internal Medicine1990 — 1992

Skills & more

Cardiovascular Medicine7Human Genetics6Translational Medicine61Clinical2Clinical Development18Clinical Trials32Pharmaceuticals1Healthcare13Life Sciences13Clinical Research37Cardiovascular Disease41Molecular Biology5

+8 more

LifesciencesMedicineOncologyCardiologyPharmaceutical IndustryImmunologyInfectious DiseasesEpidemiology

Languages English · French

From Craig's professional profile.

Frequently asked questions

Who is Craig Basson?: Chief Medical Officer, President of R&D at Variant Bio
Where does Craig Basson work?: Craig Basson is Chief Medical Officer, President of R&D at Variant Bio.
Where did Craig Basson go to school?: Craig Basson studied at Yale School of Medicine (MD, PhD, Medicine, Experimental Pathology); University of Oxford (MSc, Physiological Sciences); Washington University in St. Louis (BA, MA, Biology, French).

Same school

Also attended Yale School of Medicine73

Lars PedersenPartner, Chief Financial Officer at Redpoint Ventures Alexi Nazem, MDGeneral Partner at AlleyCorp Elias QuijanoPrincipal at Northpond Ventures Jeffrey LowPartner at Averin Capital Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear Capital Alley (Welsh) OlshanskyAdvisor at Casdin Capital

+ 67 more

Also attended University of Oxford1,763

Reid HoffmanCo-founder of LinkedIn; Partner at Greylock Michael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia Heritage Gabriel PereyraCo-founder & President of Harvey Dominic JacquessonInvestor at Index Ventures Erin Price-WrightInvestor at Index Ventures Jan HammerInvestor at Index Ventures

+ 1,757 more

Also attended Washington University in St. Louis348

Lee FixelFounder of Addition Max WechterSenior Director of AI at Lerer Hippeau Mark LevinRetired Founding Partner at Third Rock Ventures Jess OynickHead of Talent at Union Square Ventures (USV)Andrew ForysiakOwner, AJF and Associates at Riphean Investments David GoadSenior Associate, Strategic Investment at Echo Health Ventures

+ 342 more

Shared employers

Also worked at Variant Bio4

Gabrielle BertierSenior Analyst at Finchley Healthcare Ventures Rob ScottAdvisor at Apollo Health Ventures Stephane CastelCo-Founder, Chief Scientific & Technology Officer at Variant Bio Andrew FarnumChief Executive Officer at Variant Bio

Also worked at Brigham and Women's Hospital105

Nathan BlecharczykCo-founder & CSO of Airbnb Anthony PhilippakisInvestor at GV (Google Ventures)Nasra MohamedInvestor at Third Rock Ventures Alexi Nazem, MDGeneral Partner at AlleyCorp David Rosenthal, MDVenture Partner at AlleyCorp Christiana BardonManaging Partner of MPM BioImpact, leading the firm's public market investing

+ 99 more

Also worked at Harvard Medical School336

Logan HilleLife Sciences Analyst at CincyTech Ankit GuptaGeneral Partner at Y Combinator David MollerInvestor at Third Rock Ventures Samuel ArbesmanVenture Partner at Lux Capital Zach CollinsPartner at Mission Biocapital Alexi Nazem, MDGeneral Partner at AlleyCorp

+ 330 more

Also worked at Boston Pharmaceuticals5

Gretchen McCareyChief Financial Officer at Castle Island Ventures Ankur ShahVice President, CCD at Abingworth Christoph BrojaPartner at EQT Life Sciences Peter AgnesOperating Partner, B-Flexion Life Sciences at B-FLEXION Mitchell KeeganChief Development Officer at Normunity